(NASDAQ: SIBN) Si Bone's forecast annual revenue growth rate of 13.84% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.26%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.9%.
Si Bone's revenue in 2026 is $213,603,000.On average, 12 Wall Street analysts forecast SIBN's revenue for 2026 to be $10,607,660,331, with the lowest SIBN revenue forecast at $10,167,990,110, and the highest SIBN revenue forecast at $10,954,107,916. On average, 12 Wall Street analysts forecast SIBN's revenue for 2027 to be $12,271,325,835, with the lowest SIBN revenue forecast at $11,595,461,724, and the highest SIBN revenue forecast at $12,957,946,404.
In 2028, SIBN is forecast to generate $14,181,493,502 in revenue, with the lowest revenue forecast at $13,176,661,050 and the highest revenue forecast at $15,090,414,203.